Golbin, Caryl Joyce P.
HRN: 01-24-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
METRONIDAZOLE 500MG (TAB)
12/11/2023
12/18/2023
IV
500mg
Q8
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes